Todd Tushla | executive |
Kevin Gorman | executive |
Matthew Abernethy | executive |
Eric Benevich | executive |
Eiry Roberts | executive |
Philip Nadeau | analyst |
Chris Shibutani | analyst |
Paul Matteis | analyst |
Tazeen Ahmad | analyst |
Brian Abrahams | analyst |
Akash Tewari | analyst |
Joshua Schimmer | analyst |
Carter L. Gould | analyst |
Anupam Rama | analyst |
Jay Olson | analyst |
Brian Skorney | analyst |
Marc Goodman | analyst |
Lee Hung | analyst |
Myles Minter | analyst |
Yatin Suneja | analyst |
Laura Chico | analyst |
Sumant Kulkarni | analyst |
Good day, everyone, and welcome to the Neurocrine Biosciences Reports Third Quarter results. [Operator Instructions] Please note this call is being recorded and [Operator Instructions].
It is now my pleasure to turn the conference over to Todd Tushla, President of Investor Relations. Please go ahead.
Good morning.